ArticleIn silico pharmacology2021

Characterizing binding intensity and energetic features of histone deacetylase inhibitor pracinostat towards class I HDAC isozymes through futuristic drug designing strategy.

Shabir Ahmad GanaiPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.